Prioty Islam

Hematology | Oncology
650 Commack Rd
Commack, NY 11725

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Journal: Lancet (London, England)
Published: May 06, 2026

Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

Journal: Blood advances
Published: February 24, 2026

Molecular and Structural Basis of Pan-Resistance to BTK Degraders and Inhibitors.

Molecular and Structural Basis of Pan-Resistance to BTK Degraders and Inhibitors.

Journal: Cancer discovery
Published: February 05, 2026

Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era.

Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era.

Journal: American journal of hematology
Published: May 07, 2025

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.

Journal: Blood cancer journal
Published: January 10, 2025

Current Treatment Options in Relapsed and Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: a Review.

Current Treatment Options in Relapsed and Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: a Review.

Journal: Current treatment options in oncology
Published: May 15, 2023

Phase II Study of Single-Agent and Combination Everolimus and Panobinostat in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Phase II Study of Single-Agent and Combination Everolimus and Panobinostat in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Journal: Cancer investigation
Published: October 13, 2021

Pan-PI3Ki targets multiple B-ALL microenvironment interactions that fuel systemic and CNS relapse.

Pan-PI3Ki targets multiple B-ALL microenvironment interactions that fuel systemic and CNS relapse.

Journal: Leukemia & lymphoma
Published: August 06, 2021

Female Sex Is Associated with Improved Long-Term Survival Following Allogeneic Hematopoietic Stem Cell Transplantation.

Female Sex Is Associated with Improved Long-Term Survival Following Allogeneic Hematopoietic Stem Cell Transplantation.

Journal: Transplantation and cellular therapy
Published: April 02, 2021

Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies.

Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies.

Journal: Transplantation and cellular therapy
Published: March 15, 2021

Utilizing Real-World Evidence (RWE) to Improve Care in Chronic Lymphocytic Leukemia: Challenges and Opportunities.

Utilizing Real-World Evidence (RWE) to Improve Care in Chronic Lymphocytic Leukemia: Challenges and Opportunities.

Journal: Current hematologic malignancy reports
Published: May 09, 2020

Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia.

Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia.

Journal: Haematologica
Published: February 20, 2020
Showing 1-12 of 17

Last Updated: 09/26/2026